These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13009653)

  • 1. The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate.
    TAGNON HJ; WHITMORE WF; SCHULMAN P; KRAVITZ SC
    Cancer; 1953 Jan; 6(1):63-7. PubMed ID: 13009653
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis in metastatic cancer of the prostate.
    TAGNON HJ; WHITMORE WF; SHULMAN NR
    Cancer; 1952 Jan; 5(1):9-12. PubMed ID: 14886894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypofibrinogenemia and fibrinolysis in metastatic cancer of the prostate as a rare cause of unilateral renal hemorrhage].
    STEFAN H; CHROBAK L; GROH J
    Cas Lek Cesk; 1960 Mar; 99():302-6. PubMed ID: 13833992
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulopathy, following medical therapy, for carcinoma of the prostate.
    Bern MM
    Hematology; 2005 Feb; 10(1):65-8. PubMed ID: 16019449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On a case of cancer of the prostate with bone metastases and fibrinolysis].
    MARCHAL G; DUHAMEL G; LEROUX M; NIVET M; SAMAM M
    Sangre (Barc); 1959; 30():472-7. PubMed ID: 14420870
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolysis and hypofibrinogenemia associated with cancer of the prostate: report of a case].
    HAYASHI I; YANO H; SAKURAI T; MURAKAMI F; KADOTA H; KUSAKARI K
    Hinyokika Kiyo; 1962 Jun; 8():369-79. PubMed ID: 13905572
    [No Abstract]   [Full Text] [Related]  

  • 7. FIBRINOLYSIS AND CARCINOMA OF THE PROSTATE.
    SWAN HT; KERRIDGE DF
    J Clin Pathol; 1965 May; 18(3):330-3. PubMed ID: 14304247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe hemorrhagic syndrome caused by fibrinolysis during metastatic prostate osteosis].
    SERRE H; IZARN P; SIMONL
    Rev Rhum Mal Osteoartic; 1963; 30():32-6. PubMed ID: 13988148
    [No Abstract]   [Full Text] [Related]  

  • 9. [On two cases of fibrinolysis in the course of cancers of the prostate with osseous metastases].
    MARCHAL G; ESCALIER A; DUHAMEL G; LEROUX ME; NIVET M; SAMAMA M
    Sem Hop; 1959 Oct; 35():2618-22. PubMed ID: 14420875
    [No Abstract]   [Full Text] [Related]  

  • 10. [Syndrome of prostatic fibrinolysis; hemorrhagic syndrome produced by presence in the blood of proteolytic enzyme originating in prostatic carcinomatous tissue].
    TAGNON H
    Acta Clin Belg; 1954; 9(2):99-115. PubMed ID: 13180146
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary increase of fibrinolysis in a patient with metastatic carcinoma of the prostate (author's transl)].
    Hiller E; Braun HJ
    Med Klin; 1974 Apr; 69(17):757-60. PubMed ID: 4837494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in the biochemical diagnosis of metastatic cancer of the prostate].
    RAABE S
    Zentralbl Chir; 1952; 77(43a):1888-96. PubMed ID: 13039475
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid.
    Cooper DL; Sandler AB; Wilson LD; Duffy TP
    Cancer; 1992 Aug; 70(3):656-8. PubMed ID: 1623480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryofibrinogenemia and pathologically increased fibrinolysis a patient with prostate cancer].
    BOROS M; TARNOKY K; VERECZKEY C; RAK K
    Z Klin Med; 1962; 157():68-76. PubMed ID: 13871414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorrhagic syndrome in the course of prostatic cancer. Discussion on the possibility of fibrinolysis].
    RAMIOUL H
    Acta Urol Belg; 1960 Jan; 28():93-7. PubMed ID: 14436046
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolysis in a patient with carcinoma of the prostate.
    MILLER JM; MEISEL HJ; JACKSON DA; COLLIER CS
    J Urol; 1959 May; 81(5):672-5. PubMed ID: 13655383
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by haparin.
    Straub PW; Riedler G; Frick PG
    J Clin Pathol; 1967 Mar; 20(2):152-7. PubMed ID: 5602506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On low acid phosphatase values of patients with known metastatic cancer of the prostate.
    LONDON M; McHUGH R; HUDSON PB
    Cancer Res; 1954 Nov; 14(10):718-24. PubMed ID: 13209548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypofibrinogenenia and fibrinolysis as a cause of hemorrhage in prostate carcinoma].
    STEFAN H; CHROBAK L; NERAD V; GROH J
    Z Urol; 1959 Dec; 52():735-43. PubMed ID: 13833993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute fibrinolysis disclosing cancer of the prostate with bone metastases. Efficacy of epsilon-aminocaproic acid].
    MARCHAL G; DUHAMEL G; SAMAMA M; FLANDRIN G
    Bull Mem Soc Med Hop Paris; 1963 Jan 1-8; 114():143-9. PubMed ID: 13932806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.